Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist that’s the active ingredient in Ozempic for type 2 diabetes ...

Found connects patients with licensed clinicians, personalized weight loss plans and GLP-1 treatments. Here's how to save ...

It was back in December 2021 that I felt most uncomfortable in myself and with my weight. I had gone all the way to 200lbs, ...

Weight loss drugs such as Wegovy and Mounjaro are a global phenomenon, but risks remain from bad breath and wrinkles to weight regain and loss of bone density ...

As the use of glucagon-like peptide-1 (GLP-1) receptor agonists surges, researchers are looking at the impact of GLP-1s for a ...

Competition between two of the biggest names in weight-loss drugs has moved from pharmacies and television screens into the ...

The popularization of drugs like Ozempic is shifting the way consumers spend and forcing businesses to adapt ...

Nearly one-third of prescriptions included in a new study were rejected the first time a patient attempted to fill them.

The aestetics company hope increased GLP-1 use will fuel demand for treatments addressing facial volume loss, sometimes ...

Research into GLP-1 medications is not always robust but complaints such as digestive problems are well known ...

Add Yahoo as a preferred source to see more of our stories on Google. An experimental new weight loss drug may be even more powerful than the current GLP-1s options, such as Ozempic or Wegovy, and ...

A study of nearly 40,000 adults found GLP-1 drugs such as Ozempic and Mounjaro were associated with a slightly higher risk of ...